Stämm's Bioprocessor Revolutionizes Antibody Production Efficiency
Revolutionizing Antibody Production Stämm's revolutionary developments in biotechnology have led to impressive advancements in the production of monoclonal antibodies. The company has unveiled its continuous bioreactor, the Bioprocessor, which is set to transform the landscape of antibody manufacturing. Breakthroughs in Efficiency Recent pilot studies demonstrate that...
Continue Reading